CENTER ID: | NafoA.19251.a |
ORGANISM: | Naegleria fowleri ATCC 30863 |
ASSOCIATED DISEASE: | |
CURRENT STATUS: | in PDB |
COMMUNITY REQUEST: | True |
NIH RISK GROUP: | 2 |
SELECT AGENT: | False |
NIH PRIORITY pathogens category: |
IIB |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
NafoA.19251.a.B1.GE40636 | Full length(NafoA.19251.a) | 1 | 230 |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
NafoA.19251.a.B1.PS38167 | Full length(NafoA.19251.a) | 1 | 230 |
RESOURCE | REFERENCE ID |
---|---|
EuPathDB: | AmoebaDB:NF0029300_2 |
HARVESTED ON: | 10/18/2016 |
SEQUENCED ON: | 1/19/2017 |
EXPECTED MW: | 27kDa |
OBSERVED MW: | 26kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | Moderate Expression |
SOLUBLE EXPRESSION LEVEL | Moderate Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | pass with sequence variation |
PERCENT IDENTITY: | 100 |
PERCENT COVERAGE: | 68 |
PURIFICATION DATe: | 1/10/2017 |
CONCENTRATION: | 29.3mg/ml |
OBSERVED MW: | 27kDa |
EXPRESSION LEVEL: | Moderate Expression |
PROTEIN PURIFICATION BUFFER: | SEC |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 10 |
VIAL VOLUME: | 110µl |
PERCENT IDENTITY: | 100 |
PERCENT COVERAGE: | 68 |